1st Quarter - Report

BGR GOVERNMENT AFFAIRS for ALKERMES, INC.

Period 1st Quarter 2017 Filed Apr 20, 2017 Signed by Danny McNamara

Official filing
Firm
BGR GOVERNMENT AFFAIRS
Client
ALKERMES, INC.
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Provide strategic advice and counsel on legislative or regulatory actions that could impact the biopharmaceutical industry; DEA scheduling of FDA approved products.

LobbyistCovered position, as disclosed
DAVID BOYER See prior filing
BRENT ALAN DEL MONTE See prior filing
RYAN LONG See prior filing
JENNIFER LARKIN LUKAWSKI See prior filing
JONATHAN MANTZ See prior filing
ROBB WALTON New Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Healthcare Aide Sen. Enzi
ROBERT WOOD See prior filing

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.